Page last updated: 2024-10-25

amphetamine and Smoking Cessation

amphetamine has been researched along with Smoking Cessation in 1 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Smoking Cessation: Discontinuing the habit of SMOKING.

Research Excerpts

ExcerptRelevanceReference
"Varenicline is an alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist developed as an aid for smoking cessation."9.13Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. ( Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M, 2008)
"Varenicline is an alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist developed as an aid for smoking cessation."5.13Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. ( Billing, CB; Burstein, AH; McColl, SL; Reeves, KR; Sellers, EM; Stolar, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McColl, SL1
Burstein, AH1
Reeves, KR1
Billing, CB1
Stolar, M1
Sellers, EM1

Trials

1 trial available for amphetamine and Smoking Cessation

ArticleYear
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Adult; Amphetamine; Benzazepines; Central Nervous System Stimulants; Cross-Over Studies; Dose-Respon

2008